Automated Impella Controller (AIC), Product No. 0042-0000-US, 0042-0010-US, 0042-0040-US. Used w...

FDA Device Recall #Z-1175-2024 — Class II — March 1, 2021

Recall Summary

Recall Number Z-1175-2024
Classification Class II — Moderate risk
Date Initiated March 1, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abiomed, Inc.
Location Danvers, MA
Product Type Devices
Quantity 4,463 (US)

Product Description

Automated Impella Controller (AIC), Product No. 0042-0000-US, 0042-0010-US, 0042-0040-US. Used with Impella Ventricular Support Systems (cardiovascular)

Reason for Recall

Retrospective reporting for the release of Technical Bulletin IMP-2643 AIC Version 8.5 Software Update Available. The update resolved an issue in version 8.4 where a pump was not recognized by the AIC.

Distribution Pattern

US Nationwide distribution.

Lot / Code Information

Product Code 0042-0000-US UDI-DI 00813502010022; Product Code 0042-0010-US UDI-DI 00813502010985; Product Code 0042-0040-US UDI-DI 00813502011401; Software Versions V8.4 and V8.4.1

Other Recalls from Abiomed, Inc.

Recall # Classification Product Date
Z-1470-2026 Class I Impella RP Flex with SmartAssist. Product Code:... Jan 27, 2026
Z-1471-2026 Class I Impella RP. Product Code: 0046-0011. Jan 27, 2026
Z-1469-2026 Class I Impella RP with SmartAssist. Product Code: 0046... Jan 27, 2026
Z-1030-2026 Class II Impella 5.5 with SmartAssist¿ S2, Impella 5.5 w... Dec 4, 2025
Z-0069-2026 Class I Automated Impella Controller (AIC), used for le... Oct 1, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.